GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: depemokimab-ulaa | Exdensur® | GSK-3511294 | GSK3511294
depemokimab is an approved drug
Compound class:
Antibody
Comment: Depemokimab (GSK-3511294) is a humanized IgG1κ monoclonal; antibody that targets interleukin 5 (IL-5). It binds to the same epitope as, but with higher affinity mepolizumab [4].
|
Classification ![]() |
|
| Compound class | Antibody |
| Approved drug? | Yes. UK MHRA (2025) | US FDA (2025) |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 11449 | depemokimab |
Synonyms ![]() |
| depemokimab-ulaa | Exdensur® | GSK-3511294 | GSK3511294 |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 1078 |
| Other databases | |
| Search PubMed clinical trials | depemokimab |
| Search PubMed titles | depemokimab |
| Search PubMed titles/abstracts | depemokimab |